458
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Recent Advances in the Synthesis of Quinoxalines. A Mini Review

, , , , &
Pages 634-670 | Received 07 Jun 2022, Accepted 05 Jan 2023, Published online: 17 Jan 2023
 

Abstract

Quinoxalines are an important group of N-heterocyclic compounds, which are present in a variety of natural and synthetic compounds possessing physicochemical properties and pharmacological activities. Since the earliest studies, their unique properties have led the chemical community, to embrace the challenge of synthesizing new Quinoxalines. This bioactive moiety can act as a versatile building block intermediate in synthesizing novel heterocyclic scaffolds and is considered as prime focus in medicinal chemistry research. This review aims to highlight the recent synthetic strategies and various routes employed to design and synthesize quinoxalines. Initially, we have discussed the classical methods of synthesis followed by modern methods and green methods, with an overview pertaining to their structure-activity-relationship (SAR). We entrust that, this mini review will offer a broad perspective and insights among the readers in the development of new quinoxalines scaffolds with rich bio-potent applications.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.